Global Haemophilia Treatment Market Outlook 2021: Global Opportunity and Demand Analysis, Market Forecast, 2022-2030

The global haemophilia treatment market is anticipated to rise at a value CAGR of 5.5% over 20202028. According to a study published by Insure Insights on the Global Haemophilia Treatment Market. Hemophilia is a rare blood disorder in which the blood loses its ability to form clots because it lacks sufficient blood-clotting proteins. It is an inherited genetic disorder that impairs the bodys ability to make blood clots. Product launches, signed mergers, and acquisition deals by key competitors are driving the market.

Top Driver: The surge in the number of hemophilic patients around the world has elevated the markets growth.
An increase in the number of hemophilic patients around the world is the prime factor elevating the market. Moreover, the rise of several government initiatives for haemophilia treatment and government efforts to improve public health and treat underprivileged people have positively impacted the market. The rise in R & D activities and technologically advanced healthcare infrastructure, especially in the developed and developing economies, has further boosted the market growth.
Hemophilia has made the highest segmental growth in the Global Haemophilia Treatment Market.
Based on the type, the haemophilia A segment has dominated the segmental growth. Hemophilia A is the most common kind of hemophilia. The increase in the incidence rate of haemophilia A in developing and underdeveloped regions has boosted the segmental growth. The awareness among people about the treatment of haemophilia A has further propelled the segmental growth.
In terms of the product. The recombinant factor concentrates segment has held the most remarkable share owing to the increase in the production of recombinant factor concentrates for the treatment of hemophilia. Based on treatment, the prophylaxis treatment segment has exhibited the highest share and is expected to rise with substantial growth in the forecast.
With the rise in the occurrence of people suffering from hemophilia, North America rules the Global Haemophilia Treatment Market.

The rise in the incidence of haemophilia is the key factor for the growth in the region of North America. The rise in healthcare expenditure and growth in healthcare infrastructure have positively impacted the regional market. The rise in awareness of technologically advanced products and the presence of major players like Baxter International, Inc., Pfizer, Inc., Biogen Idec, Inc., Hospira, Inc., etc. have further escalated the market. The Asia-Pacific region is anticipated to rise as the fastest-growing region in the forecast owing to the early diagnosis of diseases in countries like Japan, India, Indonesia, Malaysia, etc.
Product launches, collaborations, mergers, and acquisitions are the major strategies of competitors.
The players in the global haemophilia treatment market are fragmented. Product launches, collaborations, mergers, and acquisitions are strategies used by competitors. The key competitors in the Global Haemophilia Treatment Market are Baxter International, Inc., GrifolsSA, CSL Ltd., Octapharma AG, Novo Nordisk, Pfizer, Inc., Bayer AG, Biogen Idec, Inc., FERRING LKEMEDEL AB, and Hospira, Inc.
Bayer AG.: Bayer AG. is one of the major competitors in the global haemophilia treatment market. In June 2018, Bayer AG. announced that it had completed the acquisition of Monsanto. The deal was made for USD63 billion. The acquisition was made by Bayer AG to strengthen its agricultural capabilities.
Baxter International, Inc.: Baxter International, Inc., is a popular competitor in the global haemophilia treatment market. In September 2019, Baxter International, Inc., announced the acquisition of Cheetah Medical. This acquisition was intended by Baxter International, Inc. to expand the Specialized Patient Monitoring portfolio.

Scope of the Report

By Type
Hemophilia A
Hemophilia B
Hemophilia C
Others

By Product
Recombinant Factor Concentrates
Plasma-derived Factor Concentrates
Extended Half-life Products
Others

By Treatment
On-demand
Prophylaxis

By Region
North America
Europe
Asia Pacific
Rest Of World

Key Reasons to Purchase this Report
1. It provides a technological development map over time to understand the growth rate of the industry.
2. The report offers a dynamic method to various factors that drive or restrain the growth of the market.
3. It renders a definite analysis for changing competitive dynamics.
4. It builds a seven-year estimate based on how the market is predicted to grow.

Chapter 1 Overview And Scope
1.1 Market Vision
1.1.1 Market Definition
1.1.2 Market Scope
1.2 Market Segmentation

Chapter 2 Our Research Practice
2.1 Our Research Methodology
2.2 Data Triangulation
2.3 Data Sources
2.4 Assumptions for the study
2.5 Approach Adopted

Chapter 3 Executive Summary
3.1 Market Snapshot
3.2 Regional Snapshot
3.3 Segment Summary

Chapter 4 Covid-19 Impact Analysis
4.1 Overview
4.2 Prevalence analysis
4.3 Key Factor Impact Analysis

Chapter 5 Global Haemophilia Treatment Market Forces
5.1 Whats Driving the Market
5.2 Porters Five Forces Analysis
5.2.1 Power of Suppliers
5.2.2 Threats From New Entrants
5.2.3 Power of Buyer
5.2.4 Threat From Substitute Product
5.2.5 Degree of Competition

Chapter 6 Global Haemophilia Treatment Market -Industry Snapshots
6.1 Overview
6.1.1 Global Haemophilia Treatment Market Value, 2019 - 2028, (US$ Bn)
6.2 Market Overview
6.2.1 Drivers Analysis
6.2.2 Restraint/Challenges analysis
6.2.3 Opportunity Analysis
6.3 Supply Chain/Value Chain Analysis
6.4 Market SWOT Analysis

Chapter 7 Global Haemophilia Treatment Market Analysis, by Type
7.1 Overview
7.2 Key Findings for Haemophilia Treatment Market- By Type
7.2.1 Haemophilia Treatment Market- Hemophilia A
7.2.2 Haemophilia Treatment Market- Hemophilia B
7.2.3 Haemophilia Treatment Market- Hemophilia C
7.2.4 Haemophilia Treatment Market- Others

Chapter 8 Global Haemophilia Treatment Market Analysis, by Product
8.1 Overview
8.2 Key Findings for Haemophilia Treatment Market- By Product
8.2.1 Haemophilia Treatment Market- Recombinant Factor Concentrates
8.2.2 Haemophilia Treatment Market- Plasma-derived Factor Concentrates
8.2.3 Haemophilia Treatment Market- Extended Half-life Products
8.2.4 Haemophilia Treatment Market- Others

Chapter 9 Global Haemophilia Treatment Market Analysis, by Treatment
9.1 Overview
9.2 Key Findings for Haemophilia Treatment Market- By Treatment
9.2.1 Haemophilia Treatment Market- On-demand
9.2.2 Haemophilia Treatment Market- Prophylaxis

Chapter 10 Haemophilia Treatment Market Analysis by Region
10.1 Key Findings for Haemophilia Treatment Market- By region
10.2 Overview
10.2.1 Global Haemophilia Treatment Market Analysis, By Type, 2019 - 2028
10.2.2 Global Haemophilia Treatment Market Analysis, By Product , 2019 - 2028
10.2.3 Global Haemophilia Treatment Market Analysis, By Treatment, 2019 - 2028
10.3 Haemophilia Treatment Market North America
10.3.1 Overview
10.3.2 U.S.
10.3.3 Canada
10.3.4 Mexico
10.3.5 North America Market, By Type
10.3.6 North America Market, By Product
10.3.7 North America Market, By Treatment
10.4 Haemophilia Treatment Market Europe
10.4.1 Overview
10.4.2 Germany
10.4.3 United Kingdom
10.4.4 France
10.4.5 Italy
10.4.6 Rest Of Europe
10.4.7 Europe Market, By Type
10.4.8 Europe Market, By Product
10.4.9 Europe market by, Treatment
10.5 Haemophilia Treatment Market Asia Pacific
10.5.1 Overview
10.5.2 China
10.5.3 Japan
10.5.4 India
10.5.5 Rest of APAC
10.5.6 Asia Pacific Market, By Type
10.5.7 Asia Pacific Market, By Product
10.5.8 Asia Pacific Market, By Treatment
10.6 Haemophilia Treatment Market Rest Of World
10.6.1 Overview
10.6.2 Middle East & Africa (MEA)
10.6.3 South America
10.6.4 Rest Of World
10.6.5 South America, Middle East and Africa Market, By Type
10.6.6 South America, Middle East and Africa Market, By Product
10.6.7 South America, Middle East and Africa Market, By Treatment

Chapter 11 Market Competition Analysis
11.1 Market Share/Positioning Analysis
11.1.1 Market Positioning of Key Vendors, 2019
11.1.2 Key Strategies Adopted by the Leading Players
11.1.3 Recent Developments

Chapter 12 Company Profiles- Snapshot
12.1 Baxter International, Inc.
12.1.1 Business Fundamentals
12.1.2 Financial Snapshots
12.1.3 Product Portfolio
12.1.4 Recent Developments
12.2 Grifols SA
12.3 CSL Ltd.
12.4 Octapharma AG
12.5 Novo Nordisk
12.6 Pfizer, Inc.
12.7 Bayer AG
12.8 Biogen Idec, Inc.
12.9 FERRING LAKEMEDEL AB
12.10 Hospira, Inc.
*More than 10 Companies are profiled in this Research Report*
*Financials would be provided on a best efforts basis for private companies

Chapter 13 Appendix

List Of Tables

TABLE 1 Haemophilia Treatment market by Type 1, 2019 - 2028 (USD Million)
TABLE 2 Haemophilia Treatment market by Type 2, 2019 - 2028 (USD Million)
TABLE 3 Haemophilia Treatment market by Type 3, 2019 - 2028 (USD Million)
TABLE 4 Haemophilia Treatment market by Type 4, 2019 - 2028 (USD Million)
TABLE 5 Haemophilia Treatment market by Product 1, 2019 - 2028 (USD Million)
TABLE 6 Haemophilia Treatment market by Product 2, 2019 - 2028 (USD Million)
TABLE 7 Haemophilia Treatment market by Product 3, 2019 - 2028 (USD Million)
TABLE 8 Haemophilia Treatment market by Product 4, 2019 - 2028 (USD Million)
TABLE 9 Haemophilia Treatment market by Treatment 1, 2019 - 2028 (USD Million)
TABLE 10 Haemophilia Treatment market by Treatment 2, 2019 - 2028 (USD Million)
TABLE 11 Global Haemophilia Treatment Market Value, By Type, 2019 - 2028 (US$ Bn)
TABLE 12 Global Haemophilia Treatment Market Value, By Product , 2019 - 2028 (US$ Bn)
TABLE 13 Global Haemophilia Treatment Market Value, By Treatment, 2019 - 2028 (US$ Bn)
TABLE 14 Haemophilia Treatment Market Analysis by North America (USD Million), 2019 - 2028
TABLE 15 U.S. Haemophilia Treatment Market, 2019 - 2028 (USD Million)
TABLE 16 U.S. Haemophilia Treatment Market, By Type, 2019 - 2028 (USD Million)
TABLE 17 U.S. Haemophilia Treatment Market, By Product , 2019 - 2028 (USD Million)
TABLE 18 U.S. Haemophilia Treatment Market, By Treatment, 2019 - 2028 (USD Million)
TABLE 19 Canada Haemophilia Treatment Market, 2019 - 2028 (USD Million)
TABLE 20 Canada Haemophilia Treatment Market, By Type, 2019 - 2028 (USD Million)
TABLE 21 Canada Haemophilia Treatment Market, By Product , 2019 - 2028 (USD Million)
TABLE 22 Canada Haemophilia Treatment Market, By Treatment, 2019 - 2028 (USD Million)
TABLE 23 Mexico Haemophilia Treatment Market, 2019 - 2028 (USD Million)
TABLE 24 Mexico Haemophilia Treatment Market, By Type, 2019 - 2028 (USD Million)
TABLE 25 Mexico Haemophilia Treatment Market, By Product , 2019 - 2028 (USD Million)
TABLE 26 Mexico Haemophilia Treatment Market, By Treatment, 2019 - 2028 (USD Million)
TABLE 27 Haemophilia Treatment Market Analysis by Europe (USD Million), 2019 - 2028
TABLE 28 Germany Haemophilia Treatment Market, 2019 - 2028 (USD Million)
TABLE 29 Germany Haemophilia Treatment Market, By Type, 2019 - 2028 (USD Million)
TABLE 30 Germany Haemophilia Treatment Market, By Product , 2019 - 2028 (USD Million)
TABLE 31 Germany Haemophilia Treatment Market, By Treatment, 2019 - 2028 (USD Million)
TABLE 32 United Kingdom Haemophilia Treatment Market, 2019 - 2028 (USD Million)
TABLE 33 United Kingdom Haemophilia Treatment Market, By Type, 2019 - 2028 (USD Million)
TABLE 34 United Kingdom Haemophilia Treatment Market, By Product , 2019 - 2028 (USD Million)
TABLE 35 United Kingdom Haemophilia Treatment Market, By Treatment, 2019 - 2028 (USD Million)
TABLE 36 France Haemophilia Treatment Market, 2019 - 2028 (USD Million)
TABLE 37 France Haemophilia Treatment Market, By Type, 2019 - 2028 (USD Million)
TABLE 38 France Haemophilia Treatment Market, By Product , 2019 - 2028 (USD Million)
TABLE 39 France Haemophilia Treatment Market, By Treatment, 2019 - 2028 (USD Million)
TABLE 40 Italy Haemophilia Treatment Market, 2019 - 2028 (USD Million)
TABLE 41 Italy Haemophilia Treatment Market, By Type, 2019 - 2028 (USD Million)
TABLE 42 Italy Haemophilia Treatment Market, By Product , 2019 - 2028 (USD Million)
TABLE 43 Italy Haemophilia Treatment Market, By Treatment, 2019 - 2028 (USD Million)
TABLE 44 Rest Of Europe Haemophilia Treatment Market, 2019 - 2028 (USD Million)
TABLE 45 Rest Of Europe Haemophilia Treatment Market, By Type, 2019 - 2028 (USD Million)
TABLE 46 Rest Of Europe Haemophilia Treatment Market, By Product , 2019 - 2028 (USD Million)
TABLE 47 Rest of Europe Haemophilia Treatment Market, By Treatment, 2019 - 2028 (USD Million)
TABLE 48 Haemophilia Treatment Market Analysis by Asia Pacific (USD Million), 2019 - 2028
TABLE 49 China Haemophilia Treatment Market, 2019 - 2028 (USD Million)
TABLE 50 China Haemophilia Treatment Market, By Type, 2019 - 2028 (USD Million)
TABLE 51 China Haemophilia Treatment Market, By Product , 2019 - 2028 (USD Million)
TABLE 52 China Haemophilia Treatment Market, By Treatment, 2019 - 2028 (USD Million)
TABLE 53 Japan Haemophilia Treatment Market, 2019 - 2028 (USD Million)
TABLE 54 Japan Haemophilia Treatment Market, By Type, 2019 - 2028 (USD Million)
TABLE 55 Japan Haemophilia Treatment Market, By Product , 2019 - 2028 (USD Million)
TABLE 56 Japan Haemophilia Treatment Market, By Treatment, 2019 - 2028 (USD Million)
TABLE 57 India Haemophilia Treatment Market, 2019 - 2028 (USD Million)
TABLE 58 India Haemophilia Treatment Market, By Type, 2019 - 2028 (USD Million)
TABLE 59 India Haemophilia Treatment Market, By Product , 2019 - 2028 (USD Million)
TABLE 60 India Haemophilia Treatment Market, By Treatment, 2019 - 2028 (USD Million)
TABLE 61 Rest of APAC Haemophilia Treatment Market, 2019 - 2028 (USD Million)
TABLE 62 Rest of APAC Haemophilia Treatment Market, By Type, 2019 - 2028 (USD Million)
TABLE 63 Rest of APAC Haemophilia Treatment Market, By Product , 2019 - 2028 (USD Million)
TABLE 64 Rest of APAC Haemophilia Treatment Market, By Treatment, 2019 - 2028 (USD Million)
TABLE 65 Haemophilia Treatment Market Analysis by Rest Of World (USD Million), 2019 - 2028
TABLE 66 Middle East & Africa (MEA) Haemophilia Treatment Market, 2019 - 2028 (USD Million)
TABLE 67 Middle East & Africa (MEA) Haemophilia Treatment Market, By Type, 2019 - 2028 (USD Million)
TABLE 68 Middle East & Africa (MEA) Haemophilia Treatment Market, By Product , 2019 - 2028 (USD Million)
TABLE 69 Middle East & Africa (MEA) Market, By Treatment, 2019 - 2028 (USD Million)
TABLE 70 South America Haemophilia Treatment Market, 2019 - 2028 (USD Million)
TABLE 71 South America Haemophilia Treatment Market, By Type, 2019 - 2028 (USD Million)
TABLE 72 South America Haemophilia Treatment Market, By Product , 2019 - 2028 (USD Million)
TABLE 73 South America Haemophilia Treatment Market, By Treatment, 2019 - 2028 (USD Million)
TABLE 74 Rest Of World Haemophilia Treatment Market, 2019 - 2028 (USD Million)
TABLE 75 Rest Of World Haemophilia Treatment Market, By Type, 2019 - 2028 (USD Million)
TABLE 76 Rest Of World Haemophilia Treatment Market, By Product , 2019 - 2028 (USD Million)
TABLE 77 Rest Of World Haemophilia Treatment Market, By Treatment, 2019 - 2028 (USD Million)

List Of Figures

FIG. 1 Global Haemophilia Treatment : Market Segmentation
FIG. 2 Global Haemophilia Treatment Market: Research Methodology
FIG. 3 Top-Down and Bottom Up Approach
FIG. 4 Market Snapshot
FIG. 5 Porters Five Forces Analysis
FIG. 6 Global Haemophilia Treatment Market Value, 2019 - 2028, (US$ Bn)
FIG. 7 Supply Chain/Value Chain Analysis
FIG. 8 Global Haemophilia Treatment Market Value Contribution, By Type, 2019 & 2026 (%)
FIG. 9 Global Haemophilia Treatment Market Value Contribution, By Product , 2019 & 2026 (%)
FIG. 10 Global Haemophilia Treatment Market Value Contribution, By Treatment, 2019 & 2026 (%)
FIG. 11 Global Haemophilia Treatment Market Value, 2019 - 2028, (US$ Bn)
FIG. 12 North America Haemophilia Treatment Market Value, 2019 - 2028, (US$ Bn)
FIG. 13 Haemophilia Treatment Market Segment 1 North America
FIG. 14 Haemophilia Treatment Market Segment 2 North America
FIG. 15 Haemophilia Treatment Market Segment 3 North America
FIG. 16 Haemophilia Treatment U.S. outlook, 2019 & 2026
FIG. 17 Haemophilia Treatment Canada outlook, 2019 & 2026
FIG. 18 Haemophilia Treatment Mexico outlook, 2019 & 2026
FIG. 19 Europe Haemophilia Treatment Market Value, 2019 - 2028, (US$ Bn)
FIG. 20 Haemophilia Treatment Market Segment 1 Europe
FIG. 21 Haemophilia Treatment Market Segment 2 Europe
FIG. 22 Haemophilia Treatment Market Segment 3 Europe
FIG. 23 Haemophilia Treatment Germany outlook, 2019 & 2026
FIG. 24 Haemophilia Treatment United Kingdom outlook, 2019 & 2026
FIG. 25 Haemophilia Treatment France outlook, 2019 & 2026
FIG. 26 Haemophilia Treatment Italy outlook, 2019 & 2026
FIG. 27 Haemophilia Treatment Rest Of Europe outlook, 2019 & 2026
FIG. 28 Asia Pacific Haemophilia Treatment Market Value, 2019 - 2028, (US$ Bn)
FIG. 29 Haemophilia Treatment Market Segment 1 Asia Pacific
FIG. 30 Haemophilia Treatment Market Segment 2 Asia Pacific
FIG. 31 Haemophilia Treatment Market Segment 2 Asia Pacific
FIG. 32 Haemophilia Treatment China outlook, 2019 & 2026
FIG. 33 Haemophilia Treatment Japan outlook, 2019 & 2026
FIG. 34 Haemophilia Treatment India outlook, 2019 & 2026
FIG. 35 Haemophilia Treatment Rest of APAC outlook, 2019 & 2026
FIG. 36 Rest Of World Haemophilia Treatment Market Value, 2019 - 2028, (US$ Bn)
FIG. 37 Haemophilia Treatment Market Segment 1 Rest Of World
FIG. 38 Haemophilia Treatment Market Segment 2 Rest Of World
FIG. 39 Haemophilia Treatment Market Segment 3 Rest Of World
FIG. 40 Haemophilia Treatment Middle East & Africa (MEA) outlook, 2019 & 2026
FIG. 41 Haemophilia Treatment South America outlook, 2019 & 2026
FIG. 42 Haemophilia Treatment Rest Of World outlook, 2019 & 2026

Companies Mentioned

Biotest AG
Pfizer
CSL Behring
Biogen
Kedrion
Ferring B.V
Genentech
Novo Nordisk
Octapharma.

Fill The Form For Sample Request

Full Name*

Business Email *

E-mail

Country *

Select Country Albania Algeria Afghanistan Angola Argentina Armenia Aruba Australia Austria Azerbaijan Andorra Anguilla Bahrain Bangladesh Barbados Belarus Belgium Benin Bermuda Bhutan Bolivia Bosnia and Herzegovina Botswana Brazil Brunei Bulgaria Burkina Faso Burundi Bosnia Cambodia Cameroon Central African Republic Chad Chile China Colombia Comoros Congo (Brazzaville) Cook Islands Costa Rica Cote d Ivoire Croatia Cuba Cyprus Czech Republic Cayman Islands Denmark Djibouti Dominican Republic Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Fiji Finland France Gabon Gambia Georgia Germany Ghana Gibraltar Greece Guam Guatemala Guernsey Guinea Guinea-Bissau Guyana Haiti Honduras Hong Kong Hungary Herzegovina Iceland India Indonesia Iran Iraq Ireland Isle of Man Israel Italy Jamaica Japan Jersey Jordan Kazakhstan Kenya Kiribati Kuwait Korea Kyrgyzstan Laos Latvia Lebanon Lesotho Liberia Libya Lithuania Luxembourg Liechtenstein Macau Macedonia Madagascar Malawi Malaysia Maldives Mali Malta Marshall Islands Mauritania Mauritius Mexico Moldova Monaco Mongolia Montenegro Morocco Mozambique Myanmar Middle East & North Africa (MENA) Namibia Nauru Nepal Netherlands New Caledonia New Zealand Nicaragua Niger Nigeria North Korea Norway Oman Pakistan Palau Palestinian Territories Panama Papua New Guinea Paraguay Peru Philippines Poland Portugal Puerto Rico Palestine Qatar Romania Russia Rwanda Samoa Saudi Arabia Senegal Serbia Seychelles Sierra Leone Singapore Slovakia Slovenia Solomon Islands Somalia South Africa South Korea Spain Sri Lanka Saint Kitts and Nevis Saint Vincent and the Grenadines Sudan Suriname Swaziland Sweden Switzerland Syria Scotland San Marino Taiwan Tajikistan Tanzania Thailand Timor-Leste Togo Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Turks and Caicos Islands Tuvalu Uganda Ukraine United Arab Emirates United Kingdom United States of America Uruguay Uzbekistan Uraguay Vanuatu Venezuela Vietnam Virgin Islands Yemen Zambia Zimbabwe Canada Grenada Cape Verde Belize Curacao Republic of Srpska Antigua and Barbuda Saint Lucia Falkland Islands Faroe Islands Federated States of Micronesia Guadeloupe Martinique Montserrat Niue

Contact No *

Alternate No

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available